Halozyme Therapeutics

ISIN US40637H1095

WKN A0DLHS

Market cap (in EUR)

10,524 m

Country

United States

Sector

Healthcare

Dividend yield

0.00%

Overview

Description

Halozyme Therapeutics, Inc. is a biopharmaceutical technology platform company. It engages in developing, manufacturing, and commercializing drug-device combination products using advanced auto-injector technology that are designed to provide commercial or functional advantages such as improved convenience and tolerability, and enhanced patient comfort and adherence. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA.

Show more Show less

Healthcare Biopharmaceuticals Non-System-Specific Biopharmaceuticals United States

Financials

Key metrics

Market capitalisation, EUR	10,524 m
EPS, EUR	2.87
P/B ratio	86.3
P/E ratio	32.5
Dividend yield	0.00%

Income statement (2025)

Revenue, EUR	1,238 m
Net income, EUR	281 m
Profit margin	22.69%

What ETF is Halozyme Therapeutics in?

There are 61 ETFs which contain Halozyme Therapeutics. All of these ETFs are listed in the table below. The ETF with the largest weighting of Halozyme Therapeutics is the First Trust NYSE Arca Biotechnology UCITS ETF Acc.

ETF	Weight	Investment focus	Fund size (in m EUR)
JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (acc)	0.17%	Equity United States Small Cap	82
Amundi MSCI World Small Cap ESG Broad Transition UCITS ETF Acc	0.12%	Equity World Small Cap Climate Change	483
UBS MSCI USA Select Factor Mix UCITS ETF hEUR acc	0.03%	Equity United States Multi-Factor Strategy	8
Xtrackers MSCI World Small Cap UCITS ETF 1D	0.12%	Equity World Small Cap	15
WisdomTree BioRevolution UCITS ETF USD Acc	0.78%	Equity World Health Care Social/Environmental Biotech	33
Vanguard FTSE Global Small-Cap UCITS ETF USD Acc	0.12%	Equity World Small Cap	32
Amundi S&P 400 US Mid Cap UCITS ETF Acc	0.36%	Equity United States Mid Cap	105
UBS MSCI USA Select Factor Mix UCITS ETF USD dis	0.03%	Equity United States Multi-Factor Strategy	29
L&G Gerd Kommer Multifactor Equity UCITS ETF USD Distributing	0.01%	Equity World Multi-Factor Strategy	245
UBS MSCI USA Small Cap Selection UCITS ETF USD acc	0.37%	Equity United States Small Cap	227
Jupiter Origin Global Smaller Companies Active UCITS ETF (Acc)	1.04%	Equity World Small Cap	18
Amundi Russell 1000 Growth UCITS ETF Acc	0.04%	Equity United States Growth	618
State Street SPDR MSCI World Small Cap UCITS ETF USD Unhedged (Dist)	0.12%	Equity World Small Cap	46
Vanguard FTSE Global All-Cap UCITS ETF USD Acc	0.01%	Equity World	2,787
iShares Russell 1000 Growth UCITS ETF USD (Acc)	0.04%	Equity United States Growth	1,194
CT QR Series US Equity Active UCITS ETF USD Dist	0.02%	Equity United States Fundamental/Quality	1
State Street SPDR MSCI All Country World Investable Market UCITS ETF USD Unhedged (Acc)	0.00%	Equity World	8,272
Vanguard ESG Global All Cap UCITS ETF (USD) Distributing	0.01%	Equity World Social/Environmental	576
First Trust NYSE Arca Biotechnology UCITS ETF Acc	4.34%	Equity United States Health Care Biotech	16
CT QR Series US Equity Active UCITS ETF USD Acc	0.02%	Equity United States Fundamental/Quality	82
Franklin U.S. Equity UCITS ETF	0.16%	Equity United States Multi-Factor Strategy	56
iShares S&P Mid Cap 400 Swap UCITS ETF USD (Acc)	0.36%	Equity United States Mid Cap	7
State Street SPDR MSCI All Country World Investable Market UCITS ETF USD Unhedged (Dist)	0.00%	Equity World	239
UBS MSCI USA Select Factor Mix UCITS ETF hCHF acc	0.03%	Equity United States Multi-Factor Strategy	24
Vanguard FTSE Global All-Cap UCITS ETF USD Dist	0.01%	Equity World	91
iShares MSCI USA Small Cap ESG Enhanced CTB UCITS ETF USD (Acc)	0.21%	Equity United States Small Cap	2,485
Xtrackers MSCI World Small Cap UCITS ETF 1C	0.12%	Equity World Small Cap	139
iShares World Equity Factor Rotation Active UCITS ETF USD (Acc)	0.03%	Equity World Multi-Factor Strategy	185
Invesco Nasdaq Biotech UCITS ETF	0.82%	Equity United States Health Care Biotech	428
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)	0.82%	Equity United States Health Care Biotech	72
L&G Gerd Kommer Multifactor Equity UCITS ETF USD Accumulating	0.01%	Equity World Multi-Factor Strategy	1,487
Vanguard Russell U.S. Mid-Cap UCITS ETF USD Acc	0.09%	Equity United States Mid Cap	4
State Street SPDR MSCI USA Small Cap Value Weighted UCITS ETF USD	0.09%	Equity United States Small Cap	896
Vanguard ESG North America All Cap UCITS ETF (USD) Distributing	0.02%	Equity North America Social/Environmental	31
Invesco Dow Jones Islamic Global Developed Markets UCITS ETF Acc	0.02%	Equity World Islamic Investing	1,056
BNP Paribas Easy MSCI USA Small Cap Min TE UCITS ETF USD Acc	0.19%	Equity United States Small Cap	42
Goldman Sachs MSCI World Private Equity Return Tracker UCITS ETF USD (Acc)	0.26%	Equity World Private Equity	16
iShares Healthcare Innovation UCITS ETF	1.30%	Equity World Health Care Social/Environmental Innovation	1,329
JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (dist)	0.17%	Equity United States Small Cap	231
Vanguard Russell 1000 U.S. Growth UCITS ETF USD Acc	0.04%	Equity United States Growth	27
State Street World Small Cap Enhanced Active Equity UCITS ETF USD Unhedged (Acc)	0.22%	Equity World Small Cap	174
Vanguard FTSE Global Small-Cap UCITS ETF USD Dist	0.12%	Equity World Small Cap	11
iShares MSCI World Small Cap UCITS ETF	0.11%	Equity World Small Cap	7,903
Vanguard Russell 1000 U.S. Growth UCITS ETF USD Dis	0.04%	Equity United States Growth	0
Vanguard ESG North America All Cap UCITS ETF (USD) Accumulating	0.02%	Equity North America Social/Environmental	273
WisdomTree Megatrends UCITS ETF USD	0.04%	Equity World Social/Environmental Innovation	60
Xtrackers MSCI World Small Cap ESG UCITS ETF 1C	0.18%	Equity World Small Cap	10
BNP Paribas Easy MSCI USA Small Cap Min TE UCITS ETF EUR Acc	0.19%	Equity United States Small Cap	30
UBS MSCI USA Select Factor Mix UCITS ETF USD acc	0.03%	Equity United States Multi-Factor Strategy	113
State Street SPDR MSCI World Small Cap UCITS ETF USD Unhedged (Acc)	0.12%	Equity World Small Cap	1,738
iShares Ageing Population UCITS ETF	0.69%	Equity World Health Care Social/Environmental Ageing Population	775
iShares Nasdaq US Biotechnology UCITS ETF	0.82%	Equity United States Health Care Biotech	1,049
State Street SPDR S&P 400 U.S. Mid Cap UCITS ETF USD Unhedged (Dist)	0.36%	Equity United States Mid Cap	20
State Street SPDR S&P 400 U.S. Mid Cap UCITS ETF EUR Hedged (Dist)	0.36%	Equity United States Mid Cap	63
State Street SPDR S&P 400 U.S. Mid Cap UCITS ETF USD Unhedged (Acc)	0.36%	Equity United States Mid Cap	5,352
iShares MSCI World Small Cap CTB Enhanced ESG UCITS ETF USD (Acc)	0.11%	Equity World Small Cap	414
Xtrackers MSCI World IMI UCITS ETF 1C Capitalisation	0.01%	Equity World	24
Vanguard ESG Global All Cap UCITS ETF (USD) Accumulating	0.01%	Equity World Social/Environmental	1,136
Vanguard Russell U.S. Mid-Cap UCITS ETF USD Dist	0.09%	Equity United States Mid Cap	3
L&G Pharma Breakthrough UCITS ETF	3.57%	Equity World Health Care Innovation	25
UBS MSCI World Small Cap UCITS ETF USD acc	0.11%	Equity World Small Cap	41

Savings plan offers

Here you can find information about the savings plan availability for the stock. You can use the table to compare savings plan offers for the selected savings rate.

Select your savings amount:

Broker	Rating	Execution fee	Account fee
		0.00 €	0.00 €	View offer**
		0.00 €	0.00 €	View offer*
		0.00 €	0.00 €	View offer*
		0.00 €	0.00 €	View offer*

Detailed comparison of all offers

Source: justETF Research; as of 10/2026. The offers are sorted in the following way: 1. Rating 2. Execution fee 3. Number of stock savings plans. The number of stock savings plans is rounded. In addition to the fees charged by online brokers, additional costs may apply. The stated fees are thus exclusive of standard market spreads, commissions, product costs and third-party fees. Please note: No guarantee can be given for the completeness, correctness and accuracy of the content listed. The information on the online brokers' homepages is decisive. Investments in securities involve risks.
*Affiliate link
** Important note: We are part of the Scalable Group since 2021 and are a wholly owned subsidiary of Scalable AG. This means that we are economically connected, but operate with editorial independence. Conflicts of interest are avoided because brokers — including Scalable — are evaluated according to uniform, objective criteria. You can view these in our transparent rating system. Ultimately, it’s up to you to decide how and with whom you want to invest.

Change your settings